Pearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine Assay News Pearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine Assay
Cystic Fibrosis Foundation Invests in Pearl Diagnostics to Advance Non-Invasive Detection of Pseudomonas and Aspergillus in Cystic Fibrosis News Cystic Fibrosis Foundation Invests in Pearl Diagnostics to Advance Non-Invasive Detection of Pseudomonas and Aspergillus in Cystic Fibrosis
Carb-X funds Pearl Diagnostics to assess detection of bacterial pneumonia via urine sample. News Carb-X funds Pearl Diagnostics to assess detection of bacterial pneumonia via urine sample.
Pearl Diagnostics founder Dr. Kieren Marr’s journey to retirement — then to CEO News Pearl Diagnostics founder Dr. Kieren Marr’s journey to retirement — then to CEO
Baltimore startup raises $3.5M as it prepares to seek FDA approval for new pneumonia test NewsRecent News Baltimore startup raises $3.5M as it prepares to seek FDA approval for new pneumonia test
Pearl Diagnostics Publishes Paper in “Clinical Infectious Diseases” News Pearl Diagnostics Publishes Paper in “Clinical Infectious Diseases”
